Relmada Therapeutics, Inc. RLMD Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Relmada Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s book value per share?
- Relmada Therapeutics, Inc. (RLMD) reported book value per share of $2.53 in Q1 2026.
- How has Relmada Therapeutics, Inc.'s book value per share changed year-over-year?
- Relmada Therapeutics, Inc.'s book value per share increased by 242.3% year-over-year, from $0.74 to $2.53.
- What is the long-term trend for Relmada Therapeutics, Inc.'s book value per share?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s book value per share has grown at a -20.2% compound annual growth rate (CAGR), from $6.77 to $2.19.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.